SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-241825
Filing Date
2021-08-10
Accepted
2021-08-10 16:16:04
Documents
3
Period of Report
2021-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d214876d8k.htm 8-K 17368
2 EX-99.1 d214876dex991.htm EX-99.1 44097
3 GRAPHIC g214876logo.jpg GRAPHIC 3063
  Complete submission text file 0001193125-21-241825.txt   66975
Mailing Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121
Business Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35670 | Film No.: 211160086
SIC: 2834 Pharmaceutical Preparations